These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
270 related articles for article (PubMed ID: 38152367)
21. [Mutational Signatures Analysis of Micropapillary Components and Exploration of ZNF469 Gene in Early-stage Lung Adenocarcinoma with Ground-glass Opacities]. Xu Y; Sun Q; Wang S; Zhu H; Dong G; Meng F; Xia Z; You J; Kong X; Wu J; Chen P; Yuan F; Yu X; Ji J; Li Z; Zhu P; Sun Y; Liu T; Yin R; Xu L Zhongguo Fei Ai Za Zhi; 2024 Jan; 26(12):889-900. PubMed ID: 38151328 [TBL] [Abstract][Full Text] [Related]
22. HMMR associates with immune infiltrates and acts as a prognostic biomaker in lung adenocarcinoma. Ma X; Xie M; Xue Z; Yao J; Wang Y; Xue X; Wang J Comput Biol Med; 2022 Dec; 151(Pt A):106213. PubMed ID: 36306573 [TBL] [Abstract][Full Text] [Related]
23. Integrated analysis and validation reveal ACAP1 as a novel prognostic biomarker associated with tumor immunity in lung adenocarcinoma. Wang N; Zhu L; Xu X; Yu C; Huang X Comput Struct Biotechnol J; 2022; 20():4390-4401. PubMed ID: 36051873 [TBL] [Abstract][Full Text] [Related]
24. EZH2 as a prognostic-related biomarker in lung adenocarcinoma correlating with cell cycle and immune infiltrates. Fan K; Zhang BH; Han D; Sun YC BMC Bioinformatics; 2023 Apr; 24(1):149. PubMed ID: 37069494 [TBL] [Abstract][Full Text] [Related]
25. Pan-Cancer Integrated Analysis Identification of SASH3, a Potential Biomarker That Inhibits Lung Adenocarcinoma Progression. Chen X; Yuan Y; Ren W; Zhou F; Huang X; Pu J; Niu X; Jiang X Front Oncol; 2022; 12():927988. PubMed ID: 35756681 [TBL] [Abstract][Full Text] [Related]
26. Clinical Significance and Immunometabolism Landscapes of a Novel Recurrence-Associated Lipid Metabolism Signature In Early-Stage Lung Adenocarcinoma: A Comprehensive Analysis. Zhu M; Zeng Q; Fan T; Lei Y; Wang F; Zheng S; Wang X; Zeng H; Tan F; Sun N; Xue Q; He J Front Immunol; 2022; 13():783495. PubMed ID: 35222371 [TBL] [Abstract][Full Text] [Related]
27. Long Non-Coding RNA-TMPO-AS1 as ceRNA Binding to let-7c-5p Upregulates STRIP2 Expression and Predicts Poor Prognosis in Lung Adenocarcinoma. Wang J; Yuan Y; Tang L; Zhai H; Zhang D; Duan L; Jiang X; Li C Front Oncol; 2022; 12():921200. PubMed ID: 35774125 [TBL] [Abstract][Full Text] [Related]
28. Identification of CDK2-Related Immune Forecast Model and ceRNA in Lung Adenocarcinoma, a Pan-Cancer Analysis. Liu TT; Li R; Huo C; Li JP; Yao J; Ji XL; Qu YQ Front Cell Dev Biol; 2021; 9():682002. PubMed ID: 34409029 [TBL] [Abstract][Full Text] [Related]
29. STARD12/14 are diagnostic and prognostic biomarkers of lung adenocarcinoma associated with epigenetic regulation, immune infiltration and ferroptosis. Zhang WD; Hu DM; Shi ZE; Wang QX; Zhang MY; Liu JY; Ji XL; Qu YQ Int J Med Sci; 2023; 20(11):1427-1447. PubMed ID: 37790851 [No Abstract] [Full Text] [Related]
30. Bioinformatic prediction of miR-320a as a potential negative regulator of CDGSH iron-sulfur domain 2 ( Zhao X; Li L; Li Y; Liu Y; Wang H; Tabrizi NS; Ye Z; Zhao Z Transl Cancer Res; 2024 Aug; 13(8):4485-4499. PubMed ID: 39262456 [TBL] [Abstract][Full Text] [Related]
31. Comprehensive analysis to identify GNG7 as a prognostic biomarker in lung adenocarcinoma correlating with immune infiltrates. Wei Q; Miao T; Zhang P; Jiang B; Yan H Front Genet; 2022; 13():984575. PubMed ID: 36159963 [No Abstract] [Full Text] [Related]
32. Comprehensive Analysis of Immune Implication and Prognostic Value of Zeng Y; Zhang Z; Chen H; Fan J; Yuan W; Li J; Zhou S; Liu W Front Oncol; 2021; 11():798425. PubMed ID: 35047409 [TBL] [Abstract][Full Text] [Related]
33. Comprehensive analysis to identify a novel diagnostic marker of lung adenocarcinoma and its immune infiltration landscape. Zhu A; Pei D; Zong Y; Fan Y; Wei S; Xing Z; Song S; Wang X; Gao X Front Oncol; 2023; 13():1199608. PubMed ID: 37409245 [TBL] [Abstract][Full Text] [Related]
34. Prognostic value of lncRNAs related to fatty acid metabolism in lung adenocarcinoma and their correlation with tumor microenvironment based on bioinformatics analysis. Pan YQ; Xiao Y; Long T; Liu C; Gao WH; Sun YY; Liu C; Shi YJ; Li S; Shao AZ Front Oncol; 2022; 12():1022097. PubMed ID: 36300102 [TBL] [Abstract][Full Text] [Related]
35. A new prognostic model for Li Q; Liu XL; Jiang N; Li QY; Song YX; Ke XX; Han H; Luo Q; Guo Q; Luo XY; Chen C J Thorac Dis; 2023 Apr; 15(4):1919-1934. PubMed ID: 37197482 [TBL] [Abstract][Full Text] [Related]
36. Upregulation of GNPNAT1 Predicts Poor Prognosis and Correlates With Immune Infiltration in Lung Adenocarcinoma. Liu W; Jiang K; Wang J; Mei T; Zhao M; Huang D Front Mol Biosci; 2021; 8():605754. PubMed ID: 33842535 [TBL] [Abstract][Full Text] [Related]
37. Integrated multi-omic analysis and experiment reveals the role of endoplasmic reticulum stress in lung adenocarcinoma. Liu Y; Lin W; Qian H; Yang Y; Zhou X; Wu C; Pan X; Liu Y; Wang G BMC Med Genomics; 2024 Jan; 17(1):12. PubMed ID: 38167084 [TBL] [Abstract][Full Text] [Related]
38. Identifies microtubule-binding protein Wang W; Zhang J; Wang Y; Xu Y; Zhang S Comput Struct Biotechnol J; 2022; 20():3322-3335. PubMed ID: 35832625 [TBL] [Abstract][Full Text] [Related]
39. Significance of Spliceosome-Related Genes in the Prediction of Prognosis and Treatment Strategies for Lung Adenocarcinoma. Yang Y; Huang T; Fan Y; Lu H; Shao J; Wang Y; Shen A Biomed Res Int; 2022; 2022():1753563. PubMed ID: 36389112 [TBL] [Abstract][Full Text] [Related]
40. N6-Methyladenosine RNA Methylation Regulator-Related Alternative Splicing (AS) Gene Signature Predicts Non-Small Cell Lung Cancer Prognosis. Zhao Z; Cai Q; Zhang P; He B; Peng X; Tu G; Peng W; Wang L; Yu F; Wang X Front Mol Biosci; 2021; 8():657087. PubMed ID: 34179079 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]